First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
This online seminar is designed to assist claims handlers, employers and case managers in developing an understanding of the importance of establis
On November 23, 2022, the New York State Workers’ Compensation Board
SAN DIEGO, Calif.— Mitchell, an Enlyte company and leading technology and information provider for the
The Centers for Disease Control and Prevention (CDC) released an updated and expanded recommendation for clinicians prescribing opioids for outpati
Read now